2 weeks Ago Phreesia ( NYSE: PHR ) Tuesday said that its contract with the CMS Innovation Center for use of the Patient Activation Measure has been renewed through 2029. Under the new contract, Phreesia will provide access to PAM, training, analysis and other support to the Kidney Care.
